2005
DOI: 10.3816/clm.2005.n.023
|View full text |Cite
|
Sign up to set email alerts
|

The Combination of Fludarabine, Cyclophosphamide, and Granulocyte-Macrophage Colony-Stimulating Factor in the Treatment of Patients with Relapsed Chronic Lymphocytic Leukemia and Low-Grade Non-Hodgkin's Lymphoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0
1

Year Published

2007
2007
2013
2013

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(12 citation statements)
references
References 14 publications
0
11
0
1
Order By: Relevance
“…CP is one of the most effective chemotherapeutic agents used in the treatment of cancers of breast (Levine et al, 2005;Hirano et al, 2008), lung (Sundstrom et al, 2005;Zhang et al, 2006), prostate (Nicolini et al, 2004), ovary (Donato et al, 2004), leukemia (Rao et al, 2005), lymphomas and non-Hodgkin's lymphoma. Significantly different from the CP-treated group using one-way ANOVA followed by the Tukey-Kramer multiple comparisons test (p50.05).…”
Section: Discussionmentioning
confidence: 99%
“…CP is one of the most effective chemotherapeutic agents used in the treatment of cancers of breast (Levine et al, 2005;Hirano et al, 2008), lung (Sundstrom et al, 2005;Zhang et al, 2006), prostate (Nicolini et al, 2004), ovary (Donato et al, 2004), leukemia (Rao et al, 2005), lymphomas and non-Hodgkin's lymphoma. Significantly different from the CP-treated group using one-way ANOVA followed by the Tukey-Kramer multiple comparisons test (p50.05).…”
Section: Discussionmentioning
confidence: 99%
“…However, many cyclophosphamide and fludarabine combination regimens, although highly effective, exhibited severe infectious toxicities including toxic death [1][2][3][4][5][6][7]. We designed a novel sequential regimen consisting of CVP (cyclophosphamide 400 mg/m 2 PO d1-5, vincristine 2 mg d1, prednisone 100 mg/m 2 d1-5) alternating with fludarabine (25 mg/m 2 IV d1-5) as induction chemotherapy for idiotype vaccination, with a goal of obtaining a higher quality of tumor debulking before vaccination.…”
Section: And Ronald Levymentioning
confidence: 99%
“…Various combinations of fludarabine and cyclophosphamide have been tested in clinical trials [1][2][3][4][5][6][7]. Although a high level of activity was observed in both untreated patients and patients with relapsed low-grade lymphoma, nonhematologic toxicity, especially infectious complications, hampered wide acceptance of these very effective regimens.…”
Section: And Ronald Levymentioning
confidence: 99%
See 1 more Smart Citation
“…It is the most widely used alkylating agent in the treatment of haematological malignancies and a variety of solid tumors (Demire et al, 1996-a,b;Rao et al, 2005). …”
Section: Introductionmentioning
confidence: 99%